...Good morning, and good afternoon. I'm James Gordon, JPMorgan European Pharma and Biotech analyst. And today at the JPMorgan conference, I've got the pleasure of introducing the GSK presentation and Q&A. So we have GSK CEO, Emma Walmsley, joining us for 20 minutes, and then we're going to have a 20-minute Q&A afterwards. And so with that said, thanks a lot for joining us today, Emma. Over to you for the presentation. Emma N. Walmsley ...